1. ホーム
  2. 一覧
論文 特許

論文 - 一覧

  • 26 Hits
  • 検索条件 : 絞込み (MeSH = RNA, Small Interfering / administration & dosage*)
生物種 リソース名 タイトル
ヒト・動物細胞 Y79(RCB1645) Novel epithelial cell adhesion molecule antibody conjugated polyethyleneimine-capped gold nanoparticles for enhanced and targeted small interfering RNA delivery to retinoblastoma cells.
ヒト・動物細胞 KP4(RCB1005) Nek2 siRNA therapy using a portal venous port-catheter system for liver metastasis in pancreatic cancer.
ヒト・動物細胞 HeLa(RCB0007) Enhanced cellular uptake and gene silencing activity of siRNA using temperature-responsive polymer-modified liposome.
ヒト・動物細胞 HeLa Understanding structure-activity relationships of pH-sensitive cationic lipids facilitates the rational identification of promising lipid nanoparticles for delivering siRNAs in vivo.
ヒト・動物細胞 OV2944-HM-1(RCB1483) Glypican-3 gene silencing for ovarian cancer using siRNA-PLGA hybrid micelles in a murine peritoneal dissemination model.
ヒト・動物細胞 MKN45(RCB1001) A novel intraperitoneal therapy for gastric cancer with DFP-10825, a unique RNAi therapeutic targeting thymidylate synthase, in a peritoneally disseminated xenograft model.
ヒト・動物細胞 Hep G2 Hepatocyte-Targeted Delivery of siRNA Polyplex with PEG-Modified Lactosylated Dendrimer/Cyclodextrin Conjugates for Transthyretin-Related Amyloidosis Therapy.
ヒト・動物細胞 MDA-MB-453(RCB1192) , A549 Radixin knockdown improves the accumulation and efficiency of methotrexate in tumor cells.
ヒト・動物細胞 MKN45(RCB1001) A simplified method for manufacturing RNAi therapeutics for local administration.
ヒト・動物細胞 T3M-4(RCB1021) Exosomes facilitate therapeutic targeting of oncogenic KRAS in pancreatic cancer.
ヒト・動物細胞 HeLa Neutralization of negative charges of siRNA results in improved safety and efficient gene silencing activity of lipid nanoparticles loaded with high levels of siRNA.
ヒト・動物細胞 NIH/3T3(RCB2767) Low Electric Treatment activates Rho GTPase via Heat Shock Protein 90 and Protein Kinase C for Intracellular Delivery of siRNA.
ヒト・動物細胞 Colon-26(RCB2657) In Vitro and In Vivo Tumor-Targeting siRNA Delivery Using Folate-PEG-appended Dendrimer (G4)/α-Cyclodextrin Conjugates.
ヒト・動物細胞 Colon-26(RCB2657) Design and evaluation of thioalkylated mannose-modified dendrimer (G3)/α-cyclodextrin conjugates as antigen-presenting cell-selective siRNA carriers.
ヒト・動物細胞 Colon-26(RCB2657) Preparation and evaluation of polyamidoamine dendrimer conjugate with glucuronylglucosyl-β-cyclodextrin (G3) as a novel carrier for siRNA.
ヒト・動物細胞 Hep G2 Potential use of glucuronylglucosyl-β-cyclodextrin/dendrimer conjugate (G2) as a siRNA carrier for the treatment of familial amyloidotic polyneuropathy.
ヒト・動物細胞 OVK18(RCB1903) Efficient siRNA delivery and tumor accumulation mediated by ionically cross-linked folic acid-poly(ethylene glycol)-chitosan oligosaccharide lactate nanoparticles: for the potential targeted ovarian cancer gene therapy.
ヒト・動物細胞 OS-RC-2(RCB0735) Gene silencing via RNAi and siRNA quantification in tumor tissue using MEND, a liposomal siRNA delivery system.
ヒト・動物細胞 HeLa(RCB0007) A pH-sensitive cationic lipid facilitates the delivery of liposomal siRNA and gene silencing activity in vitro and in vivo.
ヒト・動物細胞 Colon-26(RCB2657) Folate-PEG-appended dendrimer conjugate with α-cyclodextrin as a novel cancer cell-selective siRNA delivery carrier.